Clinical trial
Efficacy and Safety of OMS103HP in Patients Undergoing Autograft Anterior…
NCT00226772 · Omeros Corporation, Industry · Completed
Key facts
| NCT number | NCT00226772 |
|---|---|
| Title | Efficacy and Safety of OMS103HP in Patients Undergoing Autograft Anterior Cruciate Ligament (ACL) Reconstruction |
| Official title | Double-Blind, Multicenter Phase 3 Study Comparing the Efficacy and Safety of OMS103HP With Vehicle in Patients Undergoing Autograft ACL Reconstruction |
| Lead sponsor | Omeros Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Knee Injuries |
| Intervention type | Drug |
| Interventions | OMS103HP, Vehicle |
| Enrollment | 326 |
| Start date | Jun 1, 2005 |
| Primary completion | Sep 1, 2010 |
| Completion | Mar 1, 2011 |
| First posted | Sep 27, 2005 |
| Last update posted | Oct 12, 2012 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: